Literature DB >> 16305955

[Differentiation of neonatal rat striatal neural stem cells induced by all-trans retinoic acid].

Hong Deng1, Fei Zou, Hai-ji Luo.   

Abstract

OBJECTIVE: To investigate the role of all-trans retinoic acid (atRA) in inducing differentiation of neonatal rat striatal neural stem cells (NSCs).
METHODS: Neonatal rat striatal NSCs were obtained by mechanical isolation and serum-free culture. The roles of atRA at different concentrations in inducing the differentiation of NSCs were observed by immunofluorescent cytochemical staining, and the expression of retinoic acid receptor (RAR) gene was determined by semi-quantitative RT-PCR.
RESULTS: atRA could dose-dependently accelerate the differentiation of NSCs into neuron-like cells, and the physiological concentration of atRA was optimal for inducing NSC differentiation. atRA could induce the expression of RARbeta mRNA in a dose- and time-dependent manner.
CONCLUSION: atRA can accelerate differentiation of NSCs into neuron-likes cells and up-regulate the expression of RAR-beta mRNA in neonatal rat striatal NSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305955

Source DB:  PubMed          Journal:  Di Yi Jun Yi Da Xue Xue Bao        ISSN: 1000-2588


  3 in total

1.  Effect of all-trans retinoic acid on the differentiation of U87 glioma stem/progenitor cells.

Authors:  Zhe Shi; Meiqing Lou; Yaodong Zhao; Quanbin Zhang; Daming Cui; Ke Wang
Journal:  Cell Mol Neurobiol       Date:  2013-07-13       Impact factor: 5.046

2.  Gastrodin blocks neural stem cell differentiation into glial cells mediated by kainic acid.

Authors:  Guifang Sun; Zhihao Yuan; Boai Zhang; Yanjie Jia; Yangfei Ji; Xingrong Ma; Yu Liu; Yanru Liu; Quanqing Wen; Yanling Zhao
Journal:  Neural Regen Res       Date:  2012-04-25       Impact factor: 5.135

3.  Anti-cancer Therapies in High Grade Gliomas.

Authors:  Cristiana Pistol Tanase; Ana-Maria Enciu; Simona Mihai; Ana Iulia Neagu; Bogdan Calenic; Maria Linda Cruceru
Journal:  Curr Proteomics       Date:  2013-09       Impact factor: 0.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.